7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Atrial Remodeling D064752 1 associated lipids
Vascular Calcification D061205 1 associated lipids
Angina, Stable D060050 2 associated lipids
Bisphosphonate-Associated Osteonecrosis of the Jaw D059266 1 associated lipids
Osteoporotic Fractures D058866 1 associated lipids
Peripheral Arterial Disease D058729 7 associated lipids
Plaque, Atherosclerotic D058226 7 associated lipids
Peri-Implantitis D057873 1 associated lipids
Primary Myelofibrosis D055728 6 associated lipids
Chronic Periodontitis D055113 1 associated lipids
Osteophyte D054850 2 associated lipids
Hyperphosphatemia D054559 1 associated lipids
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative D054438 1 associated lipids
No-Reflow Phenomenon D054318 2 associated lipids
Acute Coronary Syndrome D054058 11 associated lipids
Hypercalciuria D053565 4 associated lipids
Renal Insufficiency, Chronic D051436 9 associated lipids
Fractures, Bone D050723 4 associated lipids
Arteriolosclerosis D050379 1 associated lipids
Atherosclerosis D050197 85 associated lipids
Dyslipidemias D050171 7 associated lipids
Hashimoto Disease D050031 1 associated lipids
Hyperparathyroidism, Primary D049950 1 associated lipids
Diabetes Complications D048909 4 associated lipids
Hypertension, Pregnancy-Induced D046110 2 associated lipids
Scleroderma, Limited D045745 1 associated lipids
Glucose Metabolism Disorders D044882 3 associated lipids
Malnutrition D044342 6 associated lipids
Irritable Bowel Syndrome D043183 8 associated lipids
Mastocytoma D034801 3 associated lipids
Hearing Loss D034381 3 associated lipids
Pulmonary Disease, Chronic Obstructive D029424 16 associated lipids
Spondylarthropathies D025242 1 associated lipids
Spondylarthritis D025241 1 associated lipids
Metabolic Syndrome D024821 44 associated lipids
Coronary Stenosis D023921 6 associated lipids
Carcinoma, Pancreatic Ductal D021441 6 associated lipids
Multiple Sclerosis, Relapsing-Remitting D020529 7 associated lipids
Multiple Sclerosis, Chronic Progressive D020528 3 associated lipids
Brain Infarction D020520 17 associated lipids
Osteoarthritis, Knee D020370 13 associated lipids
Lithiasis D020347 2 associated lipids
Ventricular Remodeling D020257 28 associated lipids
Tooth Ankylosis D020254 1 associated lipids
Venous Thrombosis D020246 11 associated lipids
Intracranial Hemorrhage, Traumatic D020198 1 associated lipids
Sleep Apnea, Obstructive D020181 9 associated lipids
Genetic Predisposition to Disease D020022 24 associated lipids
Hepatitis C, Chronic D019698 12 associated lipids
Hot Flashes D019584 5 associated lipids
Bone Marrow Neoplasms D019046 2 associated lipids
Myositis, Inclusion Body D018979 3 associated lipids
Sepsis D018805 11 associated lipids
Arthralgia D018771 8 associated lipids
Systemic Inflammatory Response Syndrome D018746 4 associated lipids
Breast Neoplasms, Male D018567 1 associated lipids
Bone Demineralization, Pathologic D018488 1 associated lipids
Ventricular Dysfunction, Left D018487 33 associated lipids
Cholesteatoma, Middle Ear D018424 2 associated lipids
Foot Injuries D018409 1 associated lipids
Alphavirus Infections D018354 1 associated lipids
Hemangioma, Capillary D018324 1 associated lipids
Neoplasms, Squamous Cell D018307 1 associated lipids
Carcinoma, Neuroendocrine D018278 2 associated lipids
Carcinoma, Medullary D018276 2 associated lipids
Carcinoma, Lobular D018275 4 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Adrenocortical Adenoma D018246 1 associated lipids
Fibroma, Ossifying D018214 1 associated lipids
Giant Cell Tumor of Bone D018212 1 associated lipids
Lymphangioleiomyomatosis D018192 1 associated lipids
Bone Cysts, Aneurysmal D017824 2 associated lipids
Diabetic Foot D017719 1 associated lipids
Periodontal Attachment Loss D017622 7 associated lipids
Microvascular Angina D017566 2 associated lipids
Aortic Aneurysm, Abdominal D017544 5 associated lipids
Myocardial Ischemia D017202 11 associated lipids
beta-Thalassemia D017086 5 associated lipids
Arthritis, Reactive D016918 3 associated lipids
Carotid Stenosis D016893 15 associated lipids
POEMS Syndrome D016878 1 associated lipids
Pasteurellaceae Infections D016871 2 associated lipids
Bacteroidaceae Infections D016866 2 associated lipids
Leishmaniasis, Cutaneous D016773 6 associated lipids
Diabetes, Gestational D016640 8 associated lipids
Severe Combined Immunodeficiency D016511 1 associated lipids
Peripheral Vascular Diseases D016491 8 associated lipids
Bacteremia D016470 9 associated lipids
Prosthesis-Related Infections D016459 7 associated lipids
Alveolar Bone Loss D016301 10 associated lipids
Fractures, Stress D015775 2 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Osteoporosis, Postmenopausal D015663 4 associated lipids
HIV Infections D015658 20 associated lipids
Histiocytosis, Non-Langerhans-Cell D015616 4 associated lipids
Hyperostosis D015576 1 associated lipids
Arthritis, Psoriatic D015535 3 associated lipids
Leukemia, Lymphocytic, Chronic, B-Cell D015451 25 associated lipids
Weight Loss D015431 56 associated lipids
Weight Gain D015430 101 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Verde ME et al. Effect of Bisphosphonates on the Levels of Rankl and Opg in Gingival Crevicular Fluid of Patients With Periodontal Disease and Post-menopausal Osteoporosis. 2015 Acta Odontol Latinoam pmid:27095621
Li B et al. Expression of OPG, RANKL, and RUNX2 in rabbit periodontium under orthodontic force. 2015 Genet. Mol. Res. pmid:26782591
Zang L et al. The effects of lung and prostate cancer bone metastasis on serum osteoprotegerin levels: a meta-analysis. 2015 Sci Rep pmid:26671549
Liu W et al. Polymorphisms in three genes are associated with hemorrhagic stroke. 2015 Brain Behav pmid:26664786
Pesce Viglietti AI et al. Brucella abortus Invasion of Osteocytes Modulates Connexin 43 and Integrin Expression and Induces Osteoclastogenesis via Receptor Activator of NF-κB Ligand and Tumor Necrosis Factor Alpha Secretion. 2015 Infect. Immun. pmid:26459511
Nemeth ZK et al. Serum osteoprotegerin is associated with pulse pressure in kidney transplant recipients. 2015 Sci Rep pmid:26459001
Zhang HL and Jin X Relationship between serum adiponectin and osteoprotegerin levels and coronary heart disease severity. 2015 Genet. Mol. Res. pmid:26400332
Ren H et al. Effects of intermedin on proliferation, apoptosis and the expression of OPG/RANKL/M-CSF in the MC3T3-E1 osteoblast cell line. 2015 Mol Med Rep pmid:26398911
Board-Davies E et al. Oral Mucosal Lamina Propria-Progenitor Cells Exert Antibacterial Properties via the Secretion of Osteoprotegerin and Haptoglobin. 2015 Stem Cells Transl Med pmid:26378260
Kato G et al. The inhibitory effects of a RANKL-binding peptide on articular and periarticular bone loss in a murine model of collagen-induced arthritis: a bone histomorphometric study. 2015 Arthritis Res. Ther. pmid:26373710
Li CW et al. Opg/Rankl mRNA dynamic expression in the bone tissue of ovariectomized rats with osteoporosis. 2015 Genet. Mol. Res. pmid:26345854
Pan X et al. Association of TRAIL and Its Receptors with Large-Artery Atherosclerotic Stroke. 2015 PLoS ONE pmid:26334877
Wang B et al. Chondrocytes-Specific Expression of Osteoprotegerin Modulates Osteoclast Formation in Metaphyseal Bone. 2015 Sci Rep pmid:26329493
Ostrowska Z et al. Selected pro-inflammatory cytokines, bone metabolism, osteoprotegerin, and receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa. 2015 Endokrynol Pol pmid:26323468
Kulcsar-Jakab E et al. Cystatin C as a potential predictor of osteoprotegerin levels in healthy men, a cross-sectional, observational study. 2015 BMC Musculoskelet Disord pmid:26311162
Silva Vde O et al. β-Glucans (Saccharomyces cereviseae) Reduce Glucose Levels and Attenuate Alveolar Bone Loss in Diabetic Rats with Periodontal Disease. 2015 PLoS ONE pmid:26291983
Darabi H et al. Adiponectin as a Protective Factor Against the Progression Toward Type 2 Diabetes Mellitus in Postmenopausal Women. 2015 Medicine (Baltimore) pmid:26287420
Pitari MR et al. Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts. 2015 Oncotarget pmid:26160841
Hsu BG et al. High Serum Osteoprotegerin Is Associated with Arterial Stiffness in Kidney Transplant Patients. 2015 Tohoku J. Exp. Med. pmid:26156285
Miao X et al. Nanosecond pulsed electric field inhibits proliferation and induces apoptosis in human osteosarcoma. 2015 J Orthop Surg Res pmid:26148858
Fernández-González FJ et al. Experimental evidence of pharmacological management of anchorage in Orthodontics: A systematic review. 2015 Dental Press J Orthod pmid:26560822
Bartosińska J et al. The Assessment of Selected Bone and Cartilage Biomarkers in Psoriatic Patients from Poland. 2015 Mediators Inflamm. pmid:26146462
Ye XH et al. Osteoprotegerin polymorphisms in Chinese Han patients with rheumatoid arthritis. 2015 Genet. Mol. Res. pmid:26125863
Yu SG et al. Ursolic acid derivative ameliorates streptozotocin-induced diabestic bone deleterious effects in mice. 2015 Int J Clin Exp Pathol pmid:26097549
Schmitz F et al. Repurposing an Osteoporosis Drug for β Cell Regeneration in Diabetic Patients. 2015 Cell Metab. pmid:26094892
Kondegowda NG et al. Osteoprotegerin and Denosumab Stimulate Human Beta Cell Proliferation through Inhibition of the Receptor Activator of NF-κB Ligand Pathway. 2015 Cell Metab. pmid:26094891
Telejko B et al. The association of bone turnover markers with pro- and anti-inflammatory adipokines in patients with gestational diabetes. 2015 Ann Agric Environ Med pmid:26094529
Ketlogetswe KS et al. Osteoprotegerin, but Not Receptor Activator for Nuclear Factor-κB Ligand, is Associated With Subclinical Coronary Atherosclerosis in HIV-Infected Men. 2015 J. Acquir. Immune Defic. Syndr. pmid:26090754
Burton LJ et al. Muscadine grape skin extract can antagonize Snail-cathepsin L-mediated invasion, migration and osteoclastogenesis in prostate and breast cancer cells. 2015 Carcinogenesis pmid:26069256
Collins FL et al. Death Receptor 3 (TNFRSF25) Increases Mineral Apposition by Osteoblasts and Region Specific New Bone Formation in the Axial Skeleton of Male DBA/1 Mice. 2015 J Immunol Res pmid:26065008
Zavala-Cerna MG et al. Osteoprotegerin Polymorphisms in a Mexican Population with Rheumatoid Arthritis and Generalized Osteoporosis: A Preliminary Report. 2015 J Immunol Res pmid:26065000
Davenport C et al. The Effects of Atorvastatin on Arterial Stiffness in Male Patients with Type 2 Diabetes. 2015 J Diabetes Res pmid:26064990
Rzepka R et al. Soluble receptors for advanced glycation end products and receptor activator of NF-κB ligand serum levels as markers of premature labor. 2015 BMC Pregnancy Childbirth pmid:26059227
Weichhaus M et al. Osteoprotegerin in breast cancer: beyond bone remodeling. 2015 Mol. Cancer pmid:26054853
Kastritis E et al. Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging. 2015 Blood Cancer J pmid:26047389
Shen Y et al. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway. 2015 BMC Complement Altern Med pmid:25887296
Duan P et al. Gene polymorphisms in RANKL/RANK/OPG pathway are associated with ages at menarche and natural menopause in Chinese women. 2015 BMC Womens Health pmid:25884698
Warren JT et al. Correlating RANK ligand/RANK binding kinetics with osteoclast formation and function. 2015 J. Cell. Biochem. pmid:25864714
Kim KR et al. 15-deoxy-δ12,14-prostaglandin j2 inhibits osteolytic breast cancer bone metastasis and estrogen deficiency-induced bone loss. 2015 PLoS ONE pmid:25859665
Wu C et al. Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerin. 2015 Genes Dev. pmid:25846796
Åšwierkot J et al. Assessment of the Effect of Methotrexate Therapy on Bone Metabolism in Patients with Rheumatoid Arthritis. 2015 Arch. Immunol. Ther. Exp. (Warsz.) pmid:25837853
Hassan SH et al. Effect of periodontal surgery on osteoprotegerin levels in gingival crevicular fluid, saliva, and gingival tissues of chronic periodontitis patients. 2015 Dis. Markers pmid:25814780
Folestad A et al. Role of Wnt/β-catenin and RANKL/OPG in bone healing of diabetic Charcot arthropathy patients. 2015 Acta Orthop pmid:25811776
Sutton KM et al. The functions of the avian receptor activator of NF-κB ligand (RANKL) and its receptors, RANK and osteoprotegerin, are evolutionarily conserved. 2015 Dev. Comp. Immunol. pmid:25796577
Zheng Y et al. Mesenchymal dental pulp cells attenuate dentin resorption in homeostasis. 2015 J. Dent. Res. pmid:25762594
Tsuruda T Osteoprotegerin: osteo-vascular connection. 2015 J. Atheroscler. Thromb. pmid:25740050
Shah M et al. Local origins impart conserved bone type-related differences in human osteoblast behaviour. 2015 Eur Cell Mater pmid:25738584
Alwood JS et al. Ionizing Radiation Stimulates Expression of Pro-Osteoclastogenic Genes in Marrow and Skeletal Tissue. 2015 J. Interferon Cytokine Res. pmid:25734366
Xiong L et al. Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption. 2015 Proc. Natl. Acad. Sci. U.S.A. pmid:25733894
Qiao B et al. Human mesenchymal stem cells as delivery of osteoprotegerin gene: homing and therapeutic effect for osteosarcoma. 2015 Drug Des Devel Ther pmid:25733814
Choe CH et al. Transmembrane protein 173 inhibits RANKL-induced osteoclast differentiation. 2015 FEBS Lett. pmid:25728277
Oostra DR et al. Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer. 2015 Mol. Cell. Endocrinol. pmid:25575458
Majerczyk M et al. [Osteoprotegerin as a marker of atherosclerosis and a prognostic factor in stroke]. 2015 Postepy Hig Med Dosw (Online) pmid:27259222
Fu Y et al. Involvement of the Ca²⁺ signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation. 2015 J. Vet. Sci. pmid:25549213
Lin TH et al. NF-κB decoy oligodeoxynucleotide enhanced osteogenesis in mesenchymal stem cells exposed to polyethylene particle. 2015 Tissue Eng Part A pmid:25518013
Kuroyanagi G et al. Resveratrol amplifies BMP-4-stimulated osteoprotegerin synthesis via p38 MAP kinase in osteoblasts. 2015 Mol Med Rep pmid:26044505
Kadlub N et al. The calcineurin inhibitor tacrolimus as a new therapy in severe cherubism. 2015 J. Bone Miner. Res. pmid:25491283
Rao M et al. Osteoclasts are dispensable for hematopoietic progenitor mobilization by granulocyte colony-stimulating factor in mice. 2015 Exp. Hematol. pmid:25461255
Estanislau IM et al. Pleiotropic effects of statins on the treatment of chronic periodontitis--a systematic review. 2015 Br J Clin Pharmacol pmid:25444240
Lee CJ et al. Serum osteoprotegerin is associated with arterial stiffness assessed according to the cardio-ankle vascular index in hypertensive patients. 2015 J. Atheroscler. Thromb. pmid:25318352
Meijome TE et al. GATA-1 deficiency rescues trabecular but not cortical bone in OPG deficient mice. 2015 J. Cell. Physiol. pmid:25205203
Solberg LB et al. Tartrate-resistant acid phosphatase (TRAP) co-localizes with receptor activator of NF-KB ligand (RANKL) and osteoprotegerin (OPG) in lysosomal-associated membrane protein 1 (LAMP1)-positive vesicles in rat osteoblasts and osteocytes. 2015 Histochem. Cell Biol. pmid:25201349
Potocka-Bakłażec M et al. Expression of TNF-α, OPG, IL-1β and the presence of the measles virus RNA in the stapes of the patients with otosclerosis. 2015 Eur Arch Otorhinolaryngol pmid:24676726
Esteghamati A et al. Association of osteoprotegerin with peripheral artery disease in patients with type 2 diabetes. 2015 Aug-Sep Arch Cardiovasc Dis pmid:26184866
SaÄŸlam M et al. Effect of sumac extract on serum oxidative status, RANKL/OPG system and alveolar bone loss in experimental periodontitis in rats. 2015 Jan-Feb J Appl Oral Sci pmid:25760266
Sasso GR et al. Elevated serum osteoprotegerin levels in women: friend or foe? 2015 Nov-Dec Rev Assoc Med Bras (1992) pmid:26841162
Calasans-Maia MD et al. Cytocompatibility and biocompatibility of nanostructured carbonated hydroxyapatite spheres for bone repair. 2015 Nov-Dec J Appl Oral Sci pmid:26814461
Jianru YI et al. Static compression regulates OPG expression in periodontal ligament cells via the CAMK II pathway. 2015 Nov-Dec J Appl Oral Sci pmid:26814456
Tsuruda T et al. Angiotensin II Stimulation of Cardiac Hypertrophy and Functional Decompensation in Osteoprotegerin-Deficient Mice. 2016 Hypertension pmid:27001297
Kats A et al. Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells. 2016 J. Cell. Mol. Med. pmid:26987561
Moran CS et al. Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse. 2016 Arterioscler. Thromb. Vasc. Biol. pmid:26966276
Zhou QL et al. Polydatin possesses notable anti‑osteoporotic activity via regulation of OPG, RANKL and β‑catenin. 2016 Mol Med Rep pmid:27357904
Cong Q et al. p38α MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions. 2016 Stem Cell Reports pmid:26947973
Wang C et al. Adenovirus-mediated siRNA targeting CXCR2 attenuates titanium particle-induced osteolysis by suppressing osteoclast formation. 2016 Med. Sci. Monit. pmid:26939934
Lin J et al. Increased generation of Foxp3(+) regulatory T cells by manipulating antigen presentation in the thymus. 2016 Nat Commun pmid:26923114
D'Abramo A et al. Higher Levels of Osteoprotegerin and Immune Activation/Immunosenescence Markers Are Correlated with Concomitant Bone and Endovascular Damage in HIV-Suppressed Patients. 2016 PLoS ONE pmid:26913505
Li N et al. Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats MAPK signaling. 2016 Pharmazie pmid:29441931
Lu J et al. Amlodipine and atorvastatin improved hypertensive cardiac hypertrophy through regulation of receptor activator of nuclear factor kappa B ligand/receptor activator of nuclear factor kappa B/osteoprotegerin system in spontaneous hypertension rats. 2016 Exp. Biol. Med. (Maywood) pmid:26908571
Stuss M et al. Assessment of OPG, RANKL, bone turnover markers serum levels and BMD after treatment with strontium ranelate and ibandronate in patients with postmenopausal osteoporosis. 2016 Endokrynol Pol pmid:26884284
Theodoro LH et al. Effect of low-level laser therapy as an adjuvant in the treatment of periodontitis induced in rats subjected to 5-fluorouracil chemotherapy. 2016 J. Periodont. Res. pmid:26750739
Alam I et al. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice. 2016 Endocrinology pmid:26584014
Mitchell JA et al. Genetic Risk Scores Implicated in Adult Bone Fragility Associate With Pediatric Bone Density. 2016 J. Bone Miner. Res. pmid:26572781
Zhao N et al. Isolation and Functional Analysis of an Immortalized Murine Cementocyte Cell Line, IDG-CM6. 2016 J. Bone Miner. Res. pmid:26274352
Liu YD et al. Systemic administration of strontium or NBD peptide ameliorates early stage cartilage degradation of mouse mandibular condyles. 2016 Osteoarthr. Cartil. pmid:26256766
Liu G et al. Endoplasmic reticulum stress-mediated inflammatory signaling pathways within the osteolytic periosteum and interface membrane in particle-induced osteolysis. 2016 Cell Tissue Res. pmid:26004143
Wang S et al. Anti-inflammatory and anti-arthritic effects of taraxasterol on adjuvant-induced arthritis in rats. 2016 J Ethnopharmacol pmid:27109342
Bergamini A et al. Expression of the receptor activator of nuclear factor-kB ligand in peripheral blood mononuclear cells in patients with acute Charcot neuroarthropathy. 2016 Int J Med Sci pmid:28090190
Toffoli B et al. Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System. 2016 Mediators Inflamm. pmid:28070143
Chen H et al. [Effects of laser solid forming of porous titanium on proliferation of osteoblast and RANKL/OPG expression]. 2016 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:28070039
Shimazaki E et al. TGF-β and Physiological Root Resorption of Deciduous Teeth. 2016 Int J Mol Sci pmid:28035998
Yongdi L et al. [Osteoprotegerin/receptor activator of nuclear factor-κB ligand expression in mandibular distraction osteogenesis regulated by parathyroid hormone]. 2016 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:27526445
Qian H et al. FSH aggravates bone loss in ovariectomised rats with experimental periapical periodontitis. 2016 Mol Med Rep pmid:27510616
Røysland R et al. Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study. 2016 PLoS ONE pmid:27463973
Piemontese M et al. Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. 2016 Am. J. Physiol. Endocrinol. Metab. pmid:27460899
Zhao JJ et al. MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. 2016 PLoS ONE pmid:27459539
Ugay L et al. Role of Osteoprotegerin and Receptor Activator of Nuclear Factor-κB Ligand in Bone Loss Related to Advanced Chronic Obstructive Pulmonary Disease. 2016 Chin. Med. J. pmid:27411457
Pellegrini GG et al. Avenanthramides Prevent Osteoblast and Osteocyte Apoptosis and Induce Osteoclast Apoptosis in Vitro in an Nrf2-Independent Manner. 2016 Nutrients pmid:27409635
Nagy EE et al. High circulating osteoprotegerin levels are associated with non-zero blood groups. 2016 BMC Cardiovasc Disord pmid:27387019
Zhang YY et al. Osteoprotegerin Promotes Cementoblastic Activity of Murine Cementoblast Cell Line in vitro. 2016 Chin J Dent Res pmid:27379348
Songia P et al. Mitral valve endothelial cells secrete osteoprotegerin during endothelial mesenchymal transition. 2016 J. Mol. Cell. Cardiol. pmid:27338002

Table of Content